Trial intelligence / Profile preview

Collection of Granulocytes by Apheresis of Healthy Donors Stimulated With Filgrastim and Dexamethasone

NCT01553214Phase 4Recruiting

Sponsor
National Institutes of Health
Start
Dec 2012
Primary completion
Jan 2032
Modality
Orthosteric Ligands, Cytokines & Interferons
Countries
1
01

Overview

A Phase 4 trial of filgrastim, dexamethasone, sponsored by National Institutes of Health. Started Dec 2012; status: recruiting.

02

Drugs

filgrastimdexamethasone

Beyond the preview

Go deeper on NCT01553214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01553214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call